Mateusz WnęK
Research Subjects
Research Interests
Mateusz WnęK has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Bartłomiej Andrzej Sałapski
Jan Kochanowski University, Kielce, Swietokrzyskie, Poland
4 shared publications - Dominika Brożyna
Jan Kochanowski University, Kielce, Swietokrzyskie, Poland
4 shared publications - Wojciech Kukiełka
Faculty of Medicine, Jan Kochanowski University in Kielce, al. IX Wieków Kielc 19a, 25-516 Kielce, Poland
4 shared publications - Damian GręBosz
Faculty of Medicine, Jan Kochanowski University in Kielce, al. IX Wieków Kielc 19a, 25-516 Kielce, Poland
3 shared publications - Jakub Gałwiaczek
Provincial Integrated Hospital, ul. Grunwaldzka 45, 25-736 Kielce, Poland
3 shared publications - Jarosław Dudek
St. Raphael’s Voivodeship Specialist Hospital in Czerwona Góra, ul. Czerwona Góra 10, 26-060 Chęciny, Poland
3 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
THE IMPACT OF SUGAR-SWEETENED AND SUGAR-FREE CARBONATED BEVERAGES ON DENTAL ENAMEL EROSION - LITERATURE REVIEW
Introduction and Aim: Dental erosion is defined as a non-carious loss of mineralized tooth structure caused by acids that do not originate from bacterial activity. Acidic carbonated beverages, including both sugar-sweetened and sugar-free products, represent important extrinsic factors that may contribute to enamel demineralization, surface softening, and erosive tooth wear. Although sugar-free drinks are commonly regarded as healthier alternatives to conventional soft drinks, their acidic composition may still have a harmful effect on dental tissues. The aim of this review is to compare the impact of sugar-sweetened carbonated beverages and their sugar-free equivalents on dental enamel and general health. Materials and Methods: A narrative review of the literature was performed using advanced searches in the PubMed and Google Scholar databases. English-language articles published within the last twenty years were included. The analyzed literature comprised clinical and observational studies, systematic reviews, and meta-analyses. Conclusions: Although non-caloric sweeteners may reduce sugar intake and lower the risk of dental caries associated with fermentable carbohydrates, beverages containing these sweeteners may still promote dental enamel erosion due to their acidic composition. Therefore, replacing sucrose with artificial or natural low-calorie sweeteners does not fully eliminate the potential adverse effects of soft drinks on dental hard tissues.
- 7 September 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 3 (3(51))
Open AccessTHE IMPACT OF SUGAR-SWEETENED AND SUGAR-FREE CARBONATED BEVERAGES ON DENTAL ENAMEL EROSION - LITERATURE REVIEW
Introduction and Aim: Dental erosion is defined as a non-carious loss of mineralized tooth structure caused by acids that do not originate from bacterial activity. Acidic carbonated beverages, including both sugar-sweetened and sugar-free products, represent important extrinsic factors that may contribute to enamel demineralization, surface softening, and erosive tooth wear. Although sugar-free drinks are commonly regarded as healthier alternatives to conventional soft drinks, their acidic composition may still have a harmful effect on dental tissues. The aim of this review is to compare the impact of sugar-sweetened carbonated beverages and their sugar-free equivalents on dental enamel and general health. Materials and Methods: A narrative review of the literature was performed using advanced searches in the PubMed and Google Scholar databases. English-language articles published within the last twenty years were included. The analyzed literature comprised clinical and observational studies, systematic reviews, and meta-analyses. Conclusions: Although non-caloric sweeteners may reduce sugar intake and lower the risk of dental caries associated with fermentable carbohydrates, beverages containing these sweeteners may still promote dental enamel erosion due to their acidic composition. Therefore, replacing sucrose with artificial or natural low-calorie sweeteners does not fully eliminate the potential adverse effects of soft drinks on dental hard tissues.
- Open Access
- 31 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
ISOTRETINOIN AND MOOD DISORDERS IN PATIENTS WITH ACNE VULGARIS - LITERATURE REVIEW
Introduction and Aim: Acne vulgaris is among the most prevalent dermatological conditions affecting adolescents and young adults. Visible acne lesions may considerably reduce quality of life, negatively influence self-esteem, and impair social functioning. Oral isotretinoin is widely considered the treatment of choice for severe and therapy-resistant acne. Nevertheless, concerns have long been raised regarding its potential association with psychiatric symptoms, particularly mood disturbances, depression, and suicidal behaviour. The purpose of this review is to summarise current clinical evidence concerning the relationship between isotretinoin therapy and mood disorders in patients with acne vulgaris, with particular attention to factors that may explain the observed clinical outcomes. Material and Methods: A narrative literature review was performed using advanced searches in the PubMed database. The analysis included English-language publications from the last five years, such as clinical and observational studies, systematic reviews, and meta-analyses focusing on depressive symptoms, psychiatric adverse events, and quality-of-life changes among patients receiving isotretinoin for acne vulgaris. Conclusions: The currently available evidence does not conclusively demonstrate a clinically meaningful increase in depression risk in the general population of patients treated with isotretinoin. However, in some individuals, specific vulnerability factors may increase susceptibility to mood disturbances, supporting the need for careful psychological monitoring during therapy. In many patients, improvement in acne severity is accompanied by better well-being and enhanced quality of life. Further research is required to clarify the neurobiological mechanisms underlying isotretinoin activity and to identify patients at greatest risk of psychiatric complications. These findings emphasize the importance of individualized risk–benefit assessment and close cooperation between dermatologists, general practitioners, and mental health specialists.
- 31 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessISOTRETINOIN AND MOOD DISORDERS IN PATIENTS WITH ACNE VULGARIS - LITERATURE REVIEW
Introduction and Aim: Acne vulgaris is among the most prevalent dermatological conditions affecting adolescents and young adults. Visible acne lesions may considerably reduce quality of life, negatively influence self-esteem, and impair social functioning. Oral isotretinoin is widely considered the treatment of choice for severe and therapy-resistant acne. Nevertheless, concerns have long been raised regarding its potential association with psychiatric symptoms, particularly mood disturbances, depression, and suicidal behaviour. The purpose of this review is to summarise current clinical evidence concerning the relationship between isotretinoin therapy and mood disorders in patients with acne vulgaris, with particular attention to factors that may explain the observed clinical outcomes. Material and Methods: A narrative literature review was performed using advanced searches in the PubMed database. The analysis included English-language publications from the last five years, such as clinical and observational studies, systematic reviews, and meta-analyses focusing on depressive symptoms, psychiatric adverse events, and quality-of-life changes among patients receiving isotretinoin for acne vulgaris. Conclusions: The currently available evidence does not conclusively demonstrate a clinically meaningful increase in depression risk in the general population of patients treated with isotretinoin. However, in some individuals, specific vulnerability factors may increase susceptibility to mood disturbances, supporting the need for careful psychological monitoring during therapy. In many patients, improvement in acne severity is accompanied by better well-being and enhanced quality of life. Further research is required to clarify the neurobiological mechanisms underlying isotretinoin activity and to identify patients at greatest risk of psychiatric complications. These findings emphasize the importance of individualized risk–benefit assessment and close cooperation between dermatologists, general practitioners, and mental health specialists.
- Open Access
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
IMPACT OF OPIOID DEPRESCRIBING AND TAPERING ON MENTAL HEALTH AND SOCIAL FUNCTIONING IN PATIENTS WITH CHRONIC NON – CANCER PAIN: AN OVERVIEW OF CURRENT EVIDENCE
Background. Long-term opioid therapy for chronic non-cancer pain is associated with numerous adverse effects, including psychological distress, dependence, and impaired functioning. In response to growing concerns about opioid-related harms, opioid deprescribing and tapering strategies have gained increasing attention in clinical practice. However, their impact on patients’ mental health and social functioning remains incompletely understood. Aim. This review aimed to evaluate the available evidence on the effects of opioid deprescribing and tapering on mental health and social functioning in patients with chronic non-cancer pain. Material and methods. A literature review was conducted using major biomedical databases, including PubMed, MEDLINE, Scopus, Web of Science, and the Cochrane Library. Eligible studies included peer-reviewed articles examining opioid deprescribing or tapering in adults with chronic non-cancer pain and reporting outcomes related to mental health, social functioning, or patient-reported functioning Results. The available evidence suggests that patients undergoing opioid deprescribing frequently present with substantial psychological distress, including depression, anxiety, and pain catastrophizing. Mental health outcomes during tapering are heterogeneous and influenced by the pace of dose reduction, patient involvement in decision making, and access to psychological support. Qualitative studies commonly highlight social factors: stigma, communication with healthcare providers, and availability of alternative pain management strategies. Conclusions. Opioid deprescribing in patients with chronic non-cancer pain represents a complex clinical process with potential implications for both mental health and social functioning. Individualized tapering strategies, patient involvement in treatment decisions, and adequate psychological and multidisciplinary support appear essential for minimizing adverse outcomes and improving patient experiences during opioid dose reduction.
- 28 August 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(51))
Open AccessIMPACT OF OPIOID DEPRESCRIBING AND TAPERING ON MENTAL HEALTH AND SOCIAL FUNCTIONING IN PATIENTS WITH CHRONIC NON – CANCER PAIN: AN OVERVIEW OF CURRENT EVIDENCE
Background. Long-term opioid therapy for chronic non-cancer pain is associated with numerous adverse effects, including psychological distress, dependence, and impaired functioning. In response to growing concerns about opioid-related harms, opioid deprescribing and tapering strategies have gained increasing attention in clinical practice. However, their impact on patients’ mental health and social functioning remains incompletely understood. Aim. This review aimed to evaluate the available evidence on the effects of opioid deprescribing and tapering on mental health and social functioning in patients with chronic non-cancer pain. Material and methods. A literature review was conducted using major biomedical databases, including PubMed, MEDLINE, Scopus, Web of Science, and the Cochrane Library. Eligible studies included peer-reviewed articles examining opioid deprescribing or tapering in adults with chronic non-cancer pain and reporting outcomes related to mental health, social functioning, or patient-reported functioning Results. The available evidence suggests that patients undergoing opioid deprescribing frequently present with substantial psychological distress, including depression, anxiety, and pain catastrophizing. Mental health outcomes during tapering are heterogeneous and influenced by the pace of dose reduction, patient involvement in decision making, and access to psychological support. Qualitative studies commonly highlight social factors: stigma, communication with healthcare providers, and availability of alternative pain management strategies. Conclusions. Opioid deprescribing in patients with chronic non-cancer pain represents a complex clinical process with potential implications for both mental health and social functioning. Individualized tapering strategies, patient involvement in treatment decisions, and adequate psychological and multidisciplinary support appear essential for minimizing adverse outcomes and improving patient experiences during opioid dose reduction.
- Open Access
- 17 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 94, 73183
Testosterone–Cortisol Ratio as a Marker of Training Load and Recovery in Athletes: A Narrative Review
Background: Monitoring training load and recovery is essential in athlete management, as inadequate recovery may disturb endocrine regulation and impair adaptation. Among hormonal markers, the testosterone–cortisol ratio has been proposed as an indirect indicator of the balance between anabolic and catabolic processes in response to exercise and training stress. Aim: This narrative review aimed to synthesize current evidence on the usefulness of the testosterone–cortisol ratio as a marker of training load and recovery in athletes. Materials and methods: The review included peer-reviewed original studies, systematic reviews, and meta-analyses identified through PubMed, Scopus, and Google Scholar. The literature search focused on testosterone, cortisol, testosterone–cortisol ratio, training load, exercise stress, athlete monitoring, and recovery in athletic and physically active populations. Results: Available evidence suggests that the testosterone–cortisol ratio is responsive to acute and chronic training stress, competition demands, and recovery status. Changes in the ratio may reflect shifts in anabolic–catabolic balance, but their interpretation is influenced by exercise type, training phase, circadian rhythm, individual variability, and environmental factors. Studies from different sports indicate that the ratio may be useful in longitudinal monitoring, especially when combined with external and internal load measures and subjective indicators of fatigue and recovery. Conclusions: The testosterone–cortisol ratio may provide valuable information about physiological stress and recovery in athletes, but it should not be used as a standalone marker. Its practical value appears greatest when interpreted longitudinally and integrated with broader monitoring strategies.
- 17 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 94, 73183
Open AccessTestosterone–Cortisol Ratio as a Marker of Training Load and Recovery in Athletes: A Narrative Review
Background: Monitoring training load and recovery is essential in athlete management, as inadequate recovery may disturb endocrine regulation and impair adaptation. Among hormonal markers, the testosterone–cortisol ratio has been proposed as an indirect indicator of the balance between anabolic and catabolic processes in response to exercise and training stress. Aim: This narrative review aimed to synthesize current evidence on the usefulness of the testosterone–cortisol ratio as a marker of training load and recovery in athletes. Materials and methods: The review included peer-reviewed original studies, systematic reviews, and meta-analyses identified through PubMed, Scopus, and Google Scholar. The literature search focused on testosterone, cortisol, testosterone–cortisol ratio, training load, exercise stress, athlete monitoring, and recovery in athletic and physically active populations. Results: Available evidence suggests that the testosterone–cortisol ratio is responsive to acute and chronic training stress, competition demands, and recovery status. Changes in the ratio may reflect shifts in anabolic–catabolic balance, but their interpretation is influenced by exercise type, training phase, circadian rhythm, individual variability, and environmental factors. Studies from different sports indicate that the ratio may be useful in longitudinal monitoring, especially when combined with external and internal load measures and subjective indicators of fatigue and recovery. Conclusions: The testosterone–cortisol ratio may provide valuable information about physiological stress and recovery in athletes, but it should not be used as a standalone marker. Its practical value appears greatest when interpreted longitudinally and integrated with broader monitoring strategies.
- Open Access
- 16 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 94, 72820
Patent Foramen Ovale as a Risk Factor for Neurological Decompression Sickness in Recreational Divers: A Narrative Review
Background. Decompression sickness (DCS) remains a relevant risk in recreational and professional diving. It results from inert gas (mainly nitrogen) uptake under increased pressure and subsequent bubble formation during ascent. These bubbles may affect tissues and circulation. Neurological DCS is the most severe form and may lead to permanent disability or death.Patent foramen ovale (PFO), present in approximately 25% of adults, may enable right-to-left shunting and allow venous gas emboli to bypass pulmonary filtration. This mechanism is considered a potential contributor to paradoxical embolization and central nervous system involvement. Aim. The aim of this review is to evaluate current evidence on the association between PFO and neurological DCS in recreational divers, with emphasis on diagnostic methods and clinical implications. Materials and methods. A narrative review of English-language publications (2015-2026) was conducted using PubMed and selected peer-reviewed journals in diving and cardiovascular medicine. Original research articles, systematic reviews, meta-analyses, and guidelines were included. Results. Available evidence suggests that PFO, particularly with large or high-grade right-to-left shunts, is associated with increased risk of neurological DCS. Paradoxical embolization is considered the main underlying mechanism. Diagnostic evaluation is based primarily on contrast echocardiography and transcranial Doppler. Conclusions. PFO constitutes an important but not exclusive risk factor for neurological DCS. The functional characteristics of the shunt appear to influence this risk. Routine screening is not currently recommended. Targeted evaluation and individualized risk assessment should be considered. Further prospective studies are needed to clarify optimal screening strategies and indications for PFO closure in recreational divers.
- 16 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 94, 72820
Open AccessPatent Foramen Ovale as a Risk Factor for Neurological Decompression Sickness in Recreational Divers: A Narrative Review
Background. Decompression sickness (DCS) remains a relevant risk in recreational and professional diving. It results from inert gas (mainly nitrogen) uptake under increased pressure and subsequent bubble formation during ascent. These bubbles may affect tissues and circulation. Neurological DCS is the most severe form and may lead to permanent disability or death.Patent foramen ovale (PFO), present in approximately 25% of adults, may enable right-to-left shunting and allow venous gas emboli to bypass pulmonary filtration. This mechanism is considered a potential contributor to paradoxical embolization and central nervous system involvement. Aim. The aim of this review is to evaluate current evidence on the association between PFO and neurological DCS in recreational divers, with emphasis on diagnostic methods and clinical implications. Materials and methods. A narrative review of English-language publications (2015-2026) was conducted using PubMed and selected peer-reviewed journals in diving and cardiovascular medicine. Original research articles, systematic reviews, meta-analyses, and guidelines were included. Results. Available evidence suggests that PFO, particularly with large or high-grade right-to-left shunts, is associated with increased risk of neurological DCS. Paradoxical embolization is considered the main underlying mechanism. Diagnostic evaluation is based primarily on contrast echocardiography and transcranial Doppler. Conclusions. PFO constitutes an important but not exclusive risk factor for neurological DCS. The functional characteristics of the shunt appear to influence this risk. Routine screening is not currently recommended. Targeted evaluation and individualized risk assessment should be considered. Further prospective studies are needed to clarify optimal screening strategies and indications for PFO closure in recreational divers.